FEE SCHEDULES

3 Things You Need to Know about the Lab Fee Schedule

The Centers for Medicare and Medicaid Services (CMS) issued the final 2017 Clinical Laboratory Fee Schedule (CLFS) on Nov. 21. Here is a look at the three key changes you need to know about going into … [Read more...]

FEE SCHEDULES

2017 Clinical Laboratory Fee Schedule: The 3 Changes Affecting Your Reimbursement

The Centers for Medicare and Medicaid Services (CMS) issued the final 2017 Clinical Laboratory Fee Schedule (CLFS) on Nov. 21. The winners: The small group of labs that provide new specialty molecular … [Read more...]

FEE SCHEDULES

Crosswalked Codes in 2017 Clinical Laboratory Fee Schedule

CPT Code Crosswalked To 80305 (Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical … [Read more...]

FEE SCHEDULES

Are Commercial Payers Citing Proposed CMS Gapfill Rates, Trying to Negotiate Lower Reimbursement?

During the summer, the Centers for Medicare & Medicaid Services (CMS) published proposed interim gapfill prices for 15 molecular tests. The agency said it would likely publish final prices later … [Read more...]

ENFORCEMENT

CMS Bars Theranos’ California Lab from Medicare Program

Elizabeth Holmes dropped out of college to start up Theranos. Now Theranos and Holmes have been dropped from the Medicare program. Theranos has confirmed that the Centers for Medicare & Medicaid … [Read more...]

ENFORCEMENT

CMS Scrutiny Continues for Theranos

By Ron Shinkman, Editor, Laboratory Industry Report The Theranos saga has just entered its most critical state, as the Centers for Medicare & Medicaid Services (CMS) recommended the company's … [Read more...]

Two Prominent Senators Push CMS to Make Changes on PAMA Rules

The Congressional pressure on the Centers for Medicare & Medicaid Services to make changes to its proposed final rules on the Protecting Access to Medicare Act (PAMA) have been ramped up, with two … [Read more...]

Two Prominent Senators Push CMS to Make Changes on PAMA Rules

The Congressional pressure on the Centers for Medicare & Medicaid Services to make changes to its proposed final rules on the Protecting Access to Medicare Act (PAMA) have been ramped up, with two … [Read more...]

Palmetto Issues New Codes For BRCA, “Hotspot” Testing

Medicare fiscal intermediary Palmetto GBA quietly released new payment guidelines last month for several molecular tests under its MolDx program. Palmetto issued new codes related to BRCA testing, … [Read more...]

Congressional Members Lobby CMS on PAMA Regulations

Forty-four members of House of Representatives last month asked the Centers for Medicare & Medicaid Services (CMS) to make significant changes in how the Protecting Access to Medicare Act (PAMA) … [Read more...]


(-0000g2)